| Market Cap | 12.28M | P/E | - | EPS this Y | 96.30% | Ern Qtrly Grth | - |
| Income | -10.2M | Forward P/E | -1.24 | EPS next Y | 10.20% | 50D Avg Chg | -3.00% |
| Sales | 10.51M | PEG | -0.39 | EPS past 5Y | - | 200D Avg Chg | -8.00% |
| Dividend | N/A | Price/Book | 0.84 | EPS next 5Y | 15.00% | 52W High Chg | -47.00% |
| Recommedations | 2.00 | Quick Ratio | 0.86 | Shares Outstanding | 654.85K | 52W Low Chg | 16.00% |
| Insider Own | 21.32% | ROA | -43.46% | Shares Float | 543.21K | Beta | 1.60 |
| Inst Own | 2.44% | ROE | -98.03% | Shares Shorted/Prior | 27.72K/17.79K | Price | 1.36 |
| Gross Margin | 50.09% | Profit Margin | -97.04% | Avg. Volume | 27,761 | Target Price | - |
| Oper. Margin | -76.18% | Earnings Date | Aug 6 | Volume | 80,077 | Change | -11.11% |
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
| EF Hutton | Buy | Sep 23, 22 |
| Craig-Hallum | Buy | Jan 4, 22 |
| EF Hutton | Buy | Nov 22, 21 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Bielak Benjamin | Chief Info Officer &.. Chief Info Officer & Secretary | Sep 14 | Buy | 0.72 | 18,000 | 12,960 | 84,348 | 09/15/23 |
| Curley Tracy | CEO, CFO and Treasur.. CEO, CFO and Treasurer | May 31 | Buy | 1.25 | 4,400 | 5,500 | 49,541 | 06/01/23 |
| Ianelli Christopher | Director Director | Jan 03 | Option | 1.00 | 845 | 845 | 425,359 | 01/19/23 |
| Mullan Jill | Director Director | Jan 17 | Option | 1.00 | 66,637 | 66,637 | 246,226 | 01/19/23 |
| Mullan Jill | COO & Secretary COO & Secretary | Feb 22 | Option | 1 | 22,395 | 22,395 | 200,942 | 02/23/22 |
| Ross Andrew L. | Director Director | Jun 17 | Buy | 5.74 | 4,000 | 22,960 | 1,314,524 | 11/29/21 |